We found a remarkable decrease in cellular NADPH in cells treated with BEZ235/GSK2126458 regardless of IR exposure, suggesting that the antioxidant capacity of SCLC cells was notably impaired by dual PI3K/mTOR inhibitors (Fig. 2E). This evidence concerns the gene MTOR and small cell lung carcinoma.